VYNE Therapeutics (VYNE) Operating Leases (2019 - 2024)
VYNE Therapeutics (VYNE) posted Operating Leases of $99000.0 for Q4 2024, up 296.0% on a QoQ basis from $25000.0 in Q2 2024, and little changed year-over-year from $99000.0 in Q1 2024.
VYNE Therapeutics (VYNE) Operating Leases (2019 - 2024) Analysis & Trends
VYNE Therapeutics' Operating Leases history runs 5 years deep, the most recent figure standing at $99000.0 for Q4 2024.
- Quarterly Operating Leases changed 0.0% year-over-year to $99000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $99000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $99000.0, changed 0.0% from the prior year.
- Operating Leases was $99000.0 for Q4 2024 at VYNE Therapeutics, up from $25000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $2.2 million in Q3 2020 and bottomed at $25000.0 in Q2 2024.
- A 4-year average of $762000.0 and a median of $775000.0 in 2021 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2020 — Operating Leases soared 630.0% — and 2021, when it slumped 64.61%.
- VYNE Therapeutics' Operating Leases stood at $853000.0 in 2020, then decreased by 9.14% to $775000.0 in 2021, then sank by 87.23% to $99000.0 in 2023, then changed by 0.0% to $99000.0 in 2024.
- Business Quant data shows VYNE's Operating Leases at $99000.0 in Q4 2024, $25000.0 in Q2 2024, and $63000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 99,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2021 | 775,000.00 |
| Jun 30, 2021 | 812,000.00 |
| Mar 31, 2021 | 1.43 Mn |
| Dec 31, 2020 | 853,000.00 |
| Sep 30, 2020 | 2.19 Mn |
| Jun 30, 2020 | 1.31 Mn |
| Mar 31, 2020 | 727,000.00 |
| Dec 31, 2019 | 653,000.00 |
| Sep 30, 2019 | 300,000.00 |
| Jun 30, 2019 | 715,000.00 |
| Mar 31, 2019 | 684,000.00 |